InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VUSB | 49.55 | 0.06 | +0.12% |
| Vanguard Ultra-Short Bond ETF (VUSB) | |||
| ATMP | 33.35 | -0.53 | -1.57% |
| Barclays ETN+ Select MLP ETN (ATMP) | |||
| FHDG | 36.03 | -0.82 | -2.21% |
| FT Vest U.S. Equity Quarterly Dynamic Buffer ETF (FHDG) | |||
| ENHU | 25.70 | -0.97 | -3.65% |
| iShares Enhanced Large Cap Core Active ETF (ENHU) | |||
| FLCC | 32.86 | -1.47 | -4.28% |
| Federated Hermes MDT Large Cap Core ETF (FLCC) | |||
A.I.dvisor indicates that over the last year, INFU has been loosely correlated with AMIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then AMIX could also see price increases.
| Ticker / NAME | Correlation To INFU | 1D Price Change % | ||
|---|---|---|---|---|
| INFU | 100% | +2.06% | ||
| AMIX - INFU | 44% Loosely correlated | -14.32% | ||
| VREX - INFU | 42% Loosely correlated | -0.22% | ||
| ICUI - INFU | 39% Loosely correlated | -1.84% | ||
| BFLY - INFU | 35% Loosely correlated | -7.69% | ||
| INSP - INFU | 35% Loosely correlated | -2.10% | ||
More | ||||
| Ticker / NAME | Correlation To INFU | 1D Price Change % |
|---|---|---|
| INFU | 100% | +2.06% |
| Health Services category (238 stocks) | -5% Poorly correlated | -2.69% |
| Medical/Nursing Services category (138 stocks) | -5% Poorly correlated | -3.38% |
a manufacturer of external ambulatory infusion pumps
Industry MedicalNursingServices
The 10-day RSI Indicator for INFU moved out of overbought territory on October 21, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 instances where the indicator moved out of the overbought zone. In 17 of the 21 cases the stock moved lower in the days that followed. This puts the odds of a move down at 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 58 cases where INFU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for INFU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 64 similar instances when the indicator turned negative. In 50 of the 64 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
INFU broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on INFU as a result. In 81 of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
INFU moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in 175 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 108 of 143 cases where INFU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.610) is normal, around the industry mean (4.142). P/E Ratio (32.595) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.817) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.